BBCMF (Lir Life Sciences) Ending Cash Position: $0.67 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Ending Cash Position?

Lir Life Sciences BBCMF 15 Ending Cash Position is $0.67 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's Ending Cash Position for the quarter that ended in Jan. 2026 was $0.67 Mil.

Lir Life Sciences's quarterly Ending Cash Position increased from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($1.06 Mil) but then declined from Oct. 2025 ($1.06 Mil) to Jan. 2026 ($0.67 Mil).

Lir Life Sciences's annual Ending Cash Position stayed the same from . 20 ($0.00 Mil) to Apr. 2024 ($0.00 Mil) but then increased from Apr. 2024 ($0.00 Mil) to Apr. 2025 ($0.09 Mil).

Lir Life Sciences Ending Cash Position Related Terms

Lir Life Sciences Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Ending Cash Position Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Ending Cash Position
0.00 0.09

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Ending Cash Position Get a 7-Day Free Trial 0.28 0.09 0.00 1.06 0.67
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Lir Life Sciences's Ending Cash Position for the fiscal year that ended in Apr. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.14+-0.053
=0.09

Lir Life Sciences's Ending Cash Position for the quarter that ended in Jan. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.807+-0.138
=0.67

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.67 Mil mean?
Lir Life Sciences (BBCMF) has a Ending Cash Position of $0.67 Mil as of Jan. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Ending Cash Position too high?
Lir Life Sciences' current Ending Cash Position is $0.67 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Ending Cash Position compare to VRTX and REGN?
Lir Life Sciences' Ending Cash Position of $0.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Ending Cash Position is $0.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Ending Cash Position of $0.67 Mil. The current Ending Cash Position is $0.67 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Ending Cash Position is $0.67 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price